| rdfs:label | "Novonorm"@en |
| schema:description |
"pharmaceutical product"@en
|
|
schema:date |
"2023-11-17T13:45:38+00:00"^^xsd:dateTime |
| schema:version | 2012946651 |
| wikibase:identifiers | 1 |
| wikibase:sitelinks | 0 |
| wikibase:statements | 5 |
| p:P31 | wd:statement/Q29006231-9CDAA666-86C7-4A3C-BF6F-26F3AC358318 |
| wd:statement/Q29006231-9D69C196-480D-4EF0-8C8F-DEF9A2AB8733 | |
| p:P3637 | wd:statement/Q29006231-1A301937-AE00-4C9E-B0D5-E6CB40B677E2 |
| p:P3781 | wd:statement/Q29006231-981ED323-4355-45E9-8650-79C5624024BA |
| p:P4044 | wd:statement/Q29006231-56D8DB7F-B531-471F-A119-3F6357215AF0 |
| wdt:P31 | mixture |
| pharmaceutical product | |
| wdt:P3637 | "EMEA/H/C/000187" |
| wdt:P3781 | repaglinide |
| wdt:P4044 | maturity-onset diabetes of the young type 2 |
Download as: